Benjamin Primack
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
-
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
- Oncology 7
- CAR-T cell therapy research 3
- Cancer-related Molecular Pathways 2
- Cancer Immunotherapy and Biomarkers 2
- PARP inhibition in cancer therapy 2
-
- DNA Repair Mechanisms 3
- Co-authors
- Alan D. D’Andrea (4 shared papers)Raphaël Ceccaldi (1 shared paper)Mark I.R. Petalcorin (1 shared paper)Timur Yusufzai (1 shared paper)Simon J. Boulton (1 shared paper)Ravindra Amunugama (1 shared paper)Ildikó Hajdú (1 shared paper)Panagiotis A. Konstantinopoulos (1 shared paper)
- Journals
- Cancer Research (4 papers)Molecular and Cellular Biology (1 paper)Molecular Therapy (1 paper)Molecular Cell (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Benjamin Primack
10 papers receiving 779 citations
Benjamin Primack's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 383
- Molecular Biology 642
- Cancer Research 96
- Aging 7
- Reproductive Medicine 26
Countries citing papers authored by Benjamin Primack
This map shows the geographic impact of Benjamin Primack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Primack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Primack more than expected).
Fields of papers citing papers by Benjamin Primack
This network shows the impact of papers produced by Benjamin Primack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Primack. The network helps show where Benjamin Primack may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Primack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair Hit paper breakdown → | 2015 | 677 |
| 2 | 2013 | 53 | |
| 3 | 2013 | 35 | |
| 4 | 2025 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2025 | 4 | |
| 7 | 2013 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2022 | 1 | |
| 10 | 2014 | 1 |
About Benjamin Primack
Benjamin Primack is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 10 papers that have together received 786 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers), Advanced Breast Cancer Therapies (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (383 citations), Molecular Biology (642 citations), Cancer Research (96 citations), Aging (7 citations) and Reproductive Medicine (26 citations). Benjamin Primack has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Alan D. D’Andrea, Raphaël Ceccaldi, Mark I.R. Petalcorin, Timur Yusufzai, Simon J. Boulton, Ravindra Amunugama, Ildikó Hajdú, Panagiotis A. Konstantinopoulos, Stephen J. Elledge and Kevin W. O’Connor. Their work appears in journals such as Cancer Research, Molecular and Cellular Biology, Molecular Therapy, Molecular Cell and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.